Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07821073) titled 'Myo-Inositol and Folic Acid for Improving Inflammation in Polycystic Ovary Syndrome' on Sept. 9.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).
Primary Sponsor: Khyber Medical University Peshawar
Condition:
Inflammation Biomarkers
Poly Cystic Ovary Syndrome
PCOS (Polycystic Ovary Syndrome)
Intervention:
Dietary Supplement: myo-inositol 2000 gm + folic acid 200 mcg
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: October 11, 2025
Target Sample Size: 50
Countries o...